Prenatal risk assessment tool for foetal genetic disorders only available in a h

Posted by RaynaJess on October 3rd, 2014

Abu Dhabi, UAE: Screening and diagnosis of chromosomal abnormalities in a foetus has seen a dramatic shift over the last 30 years or so. Identifying high-risk women for aneuploidies based on maternal age alone has a poor detection rate. Assessment of foetal nuchal translucency and first trimester serum biochemistry has proven to be a far superior screening test detecting 90% of foetuses with chromosomal abnormalities at a false positive rate of 3-5%. A risk assessment calculator designed by the Foetal Medicine Foundation (FMF) London is used to calculate the individual risk. Only a handful of Foetal Medicine centres in Abu Dhabi have this risk assessment tool, one of which is Danat Al Emarat Hospital for Women and Children.

Dr Gowri Ramanathan, Head of ObGyn, Director of Foetal Medicine, Danat Al Emarat Hospital for Women and Children, Abu Dhabi, UAE, will be deliberating on aneuploidy screening in pregnancy at the Obstetrics and Gynaecology Conference during the Arab Health Recruitment & Training Fair organized by Informa Life Sciences Exhibitions from 18-20 October 2014 at the Abu Dhabi National Exhibition Centre.

According to Dr Ramanathan, “This new method of risk assessment has resulted in a shift to first trimester diagnostic testing by way of chorionic villus sampling (CVS) in the high risk group of women identified by screening with nuchal translucency and serum biochemistry, and also far less diagnostic testing, which itself carries a risk of miscarriage. The nuchal translucency (NT), which is the fluid behind the foetal neck, is measured between 11-14 weeks to determine the risk of the foetus having not only a chromosomal abnormality, but also cardiac, other structural abnormality in the foetus, or a genetic disorder. This is particularly prevalent in the UAE that has high consanguinity rates.”

A new high performance test, the non-invasive prenatal testing by analysis of cell free fetal DNA in maternal blood, has been shown to have a detection rate of over 99% at a false positive rate of less than 1% for trisomy 21 and 18. The value of this test has been proven in high-risk groups, and can be considered as a primary screening test in women at increased risk of chromosomal abnormalities

“Whilst I was the Director of Foetal Medicine at Corniche Hospital in Abu Dhabi, a review of foetal medicine statistics showed that the number of women who had risk assessment using nuchal translucency was only 6%,” says Dr Ramanathan. “Furthermore, of the babies that died in pregnancy or soon after birth, only 10% of these pregnancies were booked before 12 weeks of pregnancy and only 30% before 20 weeks. These are significant figures that need to be addressed.”

With the British and American Colleges of Obstetricians and Gynaecologists recommending that all women, regardless of maternal age, be offered prenatal assessment for aneuploidy, the UAE needs to benchmark this to ensure women are better informed and able to make their own choices about their pregnancy.

About Informa Life Sciences Exhibitions:

Informa Life Sciences is part of Informa Exhibitions and runs the healthcare portfolio of products, including more than 20 exhibitions, 100 conferences yearly covering the European, African, Middle Eastern, Asian and US markets. Over the course of the year, the Informa Life Sciences’ events attract over 5,000 exhibitors, 100,000 visitors and 13,000 conference delegates. In addition to the events, the division also publishes 4 international healthcare magazines and as well as Dothealth, an on-line healthcare portal showcasing more than 40,000 healthcare companies.

For more information, please visit informalifesciences.com

For media enquiries please contact:

Weaam El Ataya

PR & Social Media Executive

Informa Life Sciences Exhibitions

T: +971 4 408 2813

F: +971 4 336 4021

weaam.elataya@informa.com

The Arab Health Recruitment and Training Fair is the region’s premier healthcare recruitment and training event. The show will host 18 free-to attend conferences across a range of clinical and non-clinical fields with 12 of the conferences offering CME accreditation points, For more information about Arab Health Recruitment and Training Fair, please call +971 408 2813 or visit www.arabhealthrecruitment.com